Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Disc Medicine, Inc. - Common Stock (NQ: IRON ) 45.67 +1.75 (+3.98%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Disc Medicine, Inc. - Common Stock < Previous 1 2 3 Next > S&P 500 Edges Lower; RH Shares Plunge After Q1 Results June 14, 2024 Via Benzinga Topics Stocks Exposures US Equities Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session June 14, 2024 Via Benzinga Gold Gains 1%; US Consumer Sentiment Falls In June June 14, 2024 Via Benzinga Hasbro, Tutor Perini, Arm Holdings And Other Big Stocks Moving Higher On Friday June 14, 2024 Via Benzinga Disc Medicine Announces Underwritten Offering of Common Stock June 14, 2024 From Disc Medicine Inc Via GlobeNewswire Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress June 14, 2024 From Disc Medicine Inc Via GlobeNewswire Disc Medicine to Participate in the Jefferies Global Healthcare Conference May 30, 2024 From Disc Medicine Inc Via GlobeNewswire Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress May 14, 2024 From Disc Medicine Inc Via GlobeNewswire Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference May 13, 2024 From Disc Medicine Inc Via GlobeNewswire IRON Stock Earnings: Disc Medicine Misses EPS for Q1 2024 May 09, 2024 IRON stock results show that Disc Medicine missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update May 09, 2024 From Disc Medicine Inc Via GlobeNewswire Top 3 Health Care Stocks You'll Regret Missing This Month April 02, 2024 The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. Via Benzinga Gold Gains 1%; CXApp Shares Spike Higher April 01, 2024 U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.3% on Monday. The Dow traded down 0.67% to 39,538.91 while the NASDAQ fell 0.06% to 16,369.44. The S&P 500 also... Via Benzinga Topics Stocks Exposures US Equities Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 01, 2024 Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results. Via Benzinga Crude Oil Moves Higher; Oxford Industries Shares Fall After Q4 Results April 01, 2024 U.S. stocks traded lower midway through trading, with the Dow Jones falling over 300 points on Monday. The Dow traded down 0.79% to 39,492.80 while the NASDAQ fell 0.22% to 16,344.11. The S&P 500 also... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 12 Health Care Stocks Moving In Monday's Intraday Session April 01, 2024 Via Benzinga Disc Medicine Stock Plunges As Light Sensitivity Treatment Data Confounded Due To Outsized Placebo Response April 01, 2024 Disc Medicine releases AURORA Phase 2 study data on bitopertin for Erythropoietic Protoporphyria. Significant reductions in PPIX levels and improvements in phototoxic reactions observed with bitopertin... Via Benzinga Disc Medicine Plummets 59% After Placebo Effect Confounds Sunlight Sensitivity Study April 01, 2024 The company is hoping to treat a rare disease that causes patients to experience severe reactions to sunlight. Via Investor's Business Daily Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) April 01, 2024 From Disc Medicine Inc Via GlobeNewswire Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update March 21, 2024 From Disc Medicine Inc Via GlobeNewswire Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024 March 06, 2024 From Disc Medicine Inc Via GlobeNewswire Week In Review: Mabwell Sells Ex-China Rights To Rare Disease Therapy In $412 Million Deal March 02, 2024 Mabwell, a Shanghai-San Diego biotech, sold ex-China rights for 9MW3011 to Disc Medicine of Watertown, MA in a deal worth up to $412 million. Meanwhile, AstraZeneca has returned most of the global... Via Talk Markets Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer February 26, 2024 Pamela Stephenson is an accomplished industry executive with over 25 years of global commercial leadership experience and a track record of numerous successful launches From Disc Medicine Inc Via GlobeNewswire Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease February 20, 2024 From Disc Medicine Inc Via GlobeNewswire Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera February 09, 2024 From Disc Medicine Inc Via GlobeNewswire Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer February 07, 2024 From Disc Medicine Inc Via GlobeNewswire Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Disc Medicine Inc Via GlobeNewswire Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory Board December 20, 2023 From Disc Medicine Inc Via GlobeNewswire Blue Bird Posts Upbeat Results, Joins Oil-Dri Corporation of America, Eagle Bulk Shipping And Other Big Stocks Moving Higher On Tuesday December 12, 2023 U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.